Back to School: How biopharma can reboot drug development. Access exclusive analysis here
IDEC Pharmaceuticals Corp. (IDPH)
Gregory Brown of Vector Securities International repeated a "buy", with
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury